In memory CD8+ T cells, CD28 expression was increased in MS, whereas naïve CD8+ T cells showed reduced CD28, BTLA, and HVEM expression compared to HCs (Figures 2G, H). This evidence concerns the gene TNFRSF14 and myeloid sarcoma.